Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 613

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies

Open access
Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Henke, St., Breipohl, G., König, W., Knolle, J., Schölkens, B.A.·1991·British Journal of Pharmacology

Abstract

Hoe 140 (d‐Arg‐[Hyp 3, Thi 5,d‐Tic 7, Oic 8]bradykinin) is a new bradykinin (BK)‐antagonist. It was tested in several in vitro assays and compared with d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK. In receptor binding studies in guinea‐pig ileum preparations, Hoe 140 showed an IC 50 of 1.07 × 10−9 mol l−1 and a KI value of 7.98 × 10−10 mol l−1. In isolated organ preparations Hoe 140 and d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK inhibited bradykinin‐induced contractions concentration dependently, with IC 50‐values in the guinea‐pig ileum preparation of 1.1 × 10−8 mol l−1 and 3 × 10−5 mol l−1, respectively. pA 2 values in this tissue were 8.42 and 6.18, respectively. In the rat uterus preparation the IC 50 value was 4.9 × 10−9 mol l−1 for Hoe 140.d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK showed an IC 50 of 4.0 × 10−6 mol l−1. The IC 50 values in the guinea‐pig isolated pulmonary artery were 5.4 × 10−9 mol l−1 and 6.4 × 10−6 mol l−1, respectively. In the rabbit aorta no inhibitory effects on Des‐Arg 9‐BK induced contractions were observed. In cultured bovine endothelial cells, Hoe 140 antagonized (IC 50= 10−8 mol l−1) bradykinin‐induced endothelium‐derived relaxing factor (EDRF) release and the bradykinin‐induced increase in cytosolic free calcium (IC 50= 10−9 mol l−1). Hoe 140 (10−7 mol l−1) totally suppressed the bradykinin‐induced (10−8 to 10−4 mol l−1) prostacyclin (PGI 2) release from cultured endothelial cells of bovine aorta.d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK (10−7 mol l−1) showed a weaker antagonism. Taken together these results show that Hoe 140 is a highly potent bradykinin antagonist. It was two to three orders of magnitude more potent than d‐Arg‐[Hyp 2, Thi 5,8,d‐Phe 7]BK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1991.tb12248.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 613

Metadata

Authors
Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., & Schölkens, B. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1991-03
Volume
102
Issue
3
Pages
769-773
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W4244444868
Cited by
613
References
11
FWCI
30.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies. https://app.cochat.ai/papers/10.1111/j.1476-5381.1991.tb12248.x
The paper
Hock, F. J., Wirth, K., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., & Schölkens, B. A. (1991). Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitro studies. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1991.tb12248.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.